Weak MGMT gene promoter methylation confers a clinically significant survival benefit in patients with newly diagnosed glioblastoma: a retrospective cohort study. https://t.co/pjvwH7RLF7 H/T @NCBI #radonc #PubMed https://t.co/1yAQfvatel
RT @JNeurooncol: New study by Pinson et al.: Even weak MGMT promoter methylation improves overall survival in #GBM #neurosurgery #neurosur…
RT @JNeurooncol: New study by Pinson et al.: Even weak MGMT promoter methylation improves overall survival in #GBM #neurosurgery #neurosur…
RT @JNeurooncol: New study by Pinson et al.: Even weak MGMT promoter methylation improves overall survival in #GBM #neurosurgery #neurosur…
RT @JNeurooncol: New study by Pinson et al.: Even weak MGMT promoter methylation improves overall survival in #GBM #neurosurgery #neurosur…
RT @JNeurooncol: New study by Pinson et al.: Even weak MGMT promoter methylation improves overall survival in #GBM #neurosurgery #neurosur…
New study by Pinson et al.: Even weak MGMT promoter methylation improves overall survival in #GBM #neurosurgery #neurosurg #nsg #neuroonc https://t.co/9QwmGZmvXb https://t.co/Zz6BAqoXjy